Document Detail


Effects of antenatal betamethasone on maternal and fetoplacental matrix metalloproteinases 2 and 9 activities in human singleton pregnancies.
MedLine Citation:
PMID:  16984797     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: A single course of antenatal betamethasone is administered to women at risk of preterm labor to advance fetal lung maturation. Matrix metalloproteinases (MMPs) are collagen-degrading enzymes that remodel extracellular matrix components during lung development. We tested the hypothesis that the effects of betamethasone on fetal lung maturation involve changes in MMP activity. METHODS: We conducted a prospective, observational pilot study of three groups of singleton pregnancies. Group 1 (n = 21) was composed of women who were antenatally treated with a single course of betamethasone and who delivered < 37 weeks of gestation, group 2 (n = 7) was composed of matched untreated women who delivered < 37 weeks of gestation, and group 3 (n = 15) was composed of untreated women who delivered > 37 weeks of gestation. Maternal blood, mixed cord blood, and placental samples were collected at the time of delivery for MMP-2 and MMP-9 activity and tissue inhibitor of metalloproteinases (TIMP)-1 and -2 levels. RESULTS: MMP-2 activity was significantly higher in the maternal, placental, and fetal compartments in group 1 compared with group 2 (p < .05). TIMP-2 levels were lower in groups 1 and 2 compared with group 3. Maternal TIMP-2 levels were higher (p < 0.003), whereas fetal TIMP-1 (p < .01) and MMP-9 to TIMP-1 ratios (p < .05) were lower when delivery was delayed more than 2 weeks following betamethasone treatment. CONCLUSION: We conclude that elevated MMP-2 activity in the maternal and fetoplacental compartments may suggest a mechanism, in part, for betamethasone-induced fetal lung maturation.
Authors:
Zahra Gharraee; Kay D A Beharry; Arwin M Valencia; Steve Cho; Leonel Guajardo; Michael P Nageotte; Houchang D Modanlou
Related Documents :
2288017 - Acute lymphoblastic leukemia in a child with hemoglobins s and q-iran.
9387967 - Comparison of helium dilution and plethysmographic lung volumes in pregnant women.
8128437 - Multi-center study of replacement of the international reference preparation for thromb...
8414757 - Retained fetal lung liquid in congenital lobar emphysema: a possible predictor of polya...
11487777 - Maternal mortality at sagamu, nigeria--a ten year review (1988 - 1997).
19084097 - Use of metformin in polycystic ovary syndrome.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of investigative medicine : the official publication of the American Federation for Clinical Research     Volume:  54     ISSN:  1081-5589     ISO Abbreviation:  J. Investig. Med.     Publication Date:  2006 Jul 
Date Detail:
Created Date:  2006-09-20     Completed Date:  2007-01-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9501229     Medline TA:  J Investig Med     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  245-54     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Division of Neonatal-Perinatal Medicine, University of California, Irvine, Orange, CA 92868, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Betamethasone / pharmacology*
Female
Fetus / drug effects*,  enzymology
Humans
Matrix Metalloproteinase 2 / metabolism*
Matrix Metalloproteinase 9 / metabolism*
Placenta / drug effects*,  enzymology
Pregnancy / metabolism*
Prospective Studies
Tissue Inhibitor of Metalloproteinase-1 / blood
Chemical
Reg. No./Substance:
0/Tissue Inhibitor of Metalloproteinase-1; 378-44-9/Betamethasone; EC 3.4.24.24/Matrix Metalloproteinase 2; EC 3.4.24.35/Matrix Metalloproteinase 9

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intradermal capsaicin causes dose-dependent pain, allodynia, and hyperalgesia in humans.
Next Document:  Diagnosis and treatment of peripheral arterial disease compared with other atherosclerotic vascular ...